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Treatment of cultured astrocytes from 2-day-old rat cerebral hemispheres with insulin or somatomedin C 
(IGF 1) promoted a rapid activation of a cytosolic protein kinase which phosphorylates ribosomal protein 
S6. Phosphorylation of substrates currently used for protein kinase assays (histone H2B and phosvitin) was 
not stimulated. Neither the cyclic AMP-dependent protein kinase activity nor that of protein kinase C was 
modified. Treatment of these astrocytes with TPA also promoted a rapid increase in S6 kinase activity in 
the cytosolic fraction. Simultaneously, protein kinase C disappeared from the cytosol. Neither cyclic AMP- 
dependent protein kinase activity nor phosvitin kinase activity was modified. The effects of insulin, IGFl 
and TPA were also observed in the presence of cycloheximide. Cycloheximide also potentiated their effects. 
These data indicate that S6 kinase activity in astrocytes is promoted from a pre-existing molecule via the 
tyrosine kinase-insulin receptor and suggest hat protein kinase C is implicated in the process. 
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1. INTRODUCTION 
Multisite phosphorylation of ribosomal protein 
S6 occurs in response to the addition of hormones 
[1,2], serum [3,4], growth factors [5-71 and phor- 
bol esters [8,9]. In vitro, S6 is a substrate for a 
number of protein kinases, e.g. CAMP and cGMP- 
dependent protein kinases [lo], protein kinase C 
[ 11,121 and casein kinase I [ 131. Only the CAMP- 
dependent protein kinase has been shown to 
phosphorylate S6 in vivo [2]. 
It has recently been reported that S6 kinase ac- 
tivity was increased in 3T3 fibroblasts treated with 
EGF [ 141, insulin and TPA [15]. While the present 
work was in progress it was also reported that in- 
sulin stimulates an S6 kinase in Xenopus oocytes 
[ 161. As phorbol ester receptors, which are be- 
lieved to be protein kinase C, and insulin and IGFl 
receptors are present in brain [ 18,191 we decided to 
look for insulin- and TPA-stimulated S6 kinase(s) 
in brain cells. The initial phase of the present 
study involved the testing of these kinase activities 
in primary cultures of astrocyte-enriched glial 
cells. 
2. MATERIALS AND METHODS 
2.1. Materials 
Histone types V-s and VII-s, phosvitin, heat- 
stable inhibitor, aprotinin, leupeptin, insulin 
(24 IU/mg), phosphatidylserine and diolein were 
from Sigma. Pure porcine insulin was obtained 
from Novo. Somatomedin C (IGFl) and 
[Y-~~P]ATP were obtained from Amersham, 
France. 12-0-Tetradecanoylphorbol 13-acetate 
(TPA) was from PL Biochemicals. All other 
chemicals were reagent grade. 
2.2. Cell culture and cell extracts 
Cerebral hemispheres from 2-day-old Sprague 
Dawley rats were cleaned of meninges and then 
dissociated into cell suspension by passage through 
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a nylon mesh (48 pm pore size). The cells were 
grown to confluence (about 14 days) as described 
[20], and then the medium was exchanged for 
chemically defined medium [21] containing in par- 
ticular insulin (10 pg/ml), hydrocortisone 
(36 fig/ml), transferrin (10 #g/ml) and selenium 
(7.8 ng/ml). The cells were maintained in this 
medium for 1 week, except that insulin was re- 
moved 2 days before experiments. 
These cultures showed predominantly glial 
fibrially acidic protein positive cells, having the 
morphological appearance of astrocytes and a high 
level of glutamine synthetase (148.83 f 19.56 nmol 
glutamine/min per mg protein). 
Insulin, IGFl or TPA were added to the medium 
for various periods. When indicated, cyclohex- 
imide (2 pg/ml) was added 30 min before hor- 
mones or TPA. Following these treatments, media 
were removed and cells were rapidly washed with 
3 ml/dish of 80 mM ,&glycerophosphate, pH 7.4, 
20 mM EGTA and 15 mM MgC12 (buffer A). 
Finally, cells were scraped off in 0.3 ml/dish of 
buffer A containing 1 mM PMSF, aprotinin 
(50 pg/ml), leupeptin (4 pg/ml), antipain (4 pg/ 
ml), trypsin inhibitor (1 pg/ml), 1 mM benzamidin 
and 0.1 mM N-cr-p-tosyl-L-lysine chloromethyl 
ketone. Cells were broken in this buffer by sonica- 
tion for 3 s. The homogenate was centrifuged at 
100000 x g for 1 h. The supernatant was stored as 
frozen aliquots at -70°C. As initially reported 
[14] for a serum- and EGF-activated S6 kinase in 
3T3 cells, the insulin-stimulated S6 kinase from 
astrocytes was stable when cells were homogenized 
in a ,&glycerophosphate-EGTA buffer and when 
cytosolic and particulate fractions were rapidly 
separated. 
2.3. Protein kinase assays 
40 S ribosomal subunits were isolated from rat 
liver according to Martin and Wool [22]. S6 kinase 
assays were performed by incubation for 20 min at 
30°C or 10 min at 37°C in a final volume of 50~1 
containing 20 mM Hepes (pH 7.4), 8 mM MgClz, 
2 mM dithiothreitol, 15-25 pg 40 S ribosomal 
protein and 50 ,uM ATP (-1-2 ,uCi/nmol). Reac- 
tion was initiated by addition of aliquots of the ex- 
tracts (5-10 pg protein) and stopped with 
concentrated electrophoresis ample buffer. Reac- 
tion products were separated by electrophoresis in 
the presence of SDS on 15% polyacrylamide gels 
[23]. The gels were stained with Coomassie blue, 
dried and-autoradiographed with Kodak XARS 
films. 32P incorporation into 40 S ribosomal pro- 
teins took place in a single band (fig.1) corre- 
sponding to a component identified as S6 [14-161. 
This band was excised from the dried gels and 32P 
was quantified by counting. 
Protein kinase C, CAMP dependent protein 
kinase and phosvitin kinase activities were assayed 
as in [24,25]. 
3. RESULTS AND DISCUSSION 
Treatment of confluent primary astrocytes 
maintained in chemically defined medium with 
1 PM insulin for 60 min promoted a 2-4-fold in- 
crease in S6 protein kinase activity (fig. 1, table 1). 
No reduction of this activity was observed in the 
d a 
2&l- 
l4- 
Fig.1. Presence in astrocytes of an S6 kinase activity 
stimulated by insulin. Astrocytes were treated with 
insulin (10e6 M) for 1 h. Cytosolic extracts were 
prepared and incubated with 40 S ribosomal subunits 
and [y-32P]ATP. Phosphorylation products were 
analyzed by gel electrophoresis and autoradiography. 
Autophosphorylation of 40 S ribosomal subunits (a) and 
of cytosolic extracts from control cells (c) or insulin- 
treated cells (e). Phosphorylation of 40 S ribosomal 
subunit by extract from control cells (b) and insulin- 
treated cells (d). 
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Table 1 
32P incorporation into various substrates catalyzed by 
cytosolic extracts from control and stimulated cells 
Substrates Unstim- Cells stimulated by 
ulated cells 
Insulin TPA 
40 s 0.018 0.038 0.065 
Histones H2B 
- CAMP 0.58 0.51 0.61 
+ CAMP 0.88 0.89 0.82 
Phosvitin 0.3 0.29 0.32 
Astrocytes were treated with insulin (10e6 M) or TPA 
(lo-’ M) for 1 h. Cytosolic extracts were prepared and 
assayed for 32P incorporation into S6, phosvitin and 
H2B in the presence or absence of CAMP. Values are 
expressed as nmol 32P/min per mg protein 
presence of the heat-stable inhibitor of CAMP- 
dependent protein kinase (fig.2). The insulin- 
stimulated S6 kinase activity was rather specific 
because no stimulation of protein kinase activity 
was seen with the substrates currently used for pro- 
tein kinase assays (histone H2B and phosvitin) 
(table 1). Moreover, CAMP-dependent protein 
kinase and protein kinase C activities were un- 
modified (fig.2, table 1). As changes in the 
specificity of kinase C have been observed [26] we 
also assayed kinase C with endogenous ubstrates 
(fig.3) but no modification was observed. 
The time course for insulin-stimulated S6 kinase 
activity is shown in fig.2. Activation was detected 
as early as 5 min after addition of insulin and in- 
creased with time for at least 1 h. The dose- 
response curve for insulin-stimulated S6 kinase is 
shown in fig.4. Stimulation was detectable with 
l-2 nM insulin and appeared to reach a maximum 
between 0.1 and 1 ,uM. The addition of cyclohex- 
imide 30 min prior to exposure to insulin did not 
suppress the stimulation of S6 kinase activity but 
had a potentiating effect (fig.4). Thus, it is likely 
that the stimulation of S6 kinase activity does not 
require protein synthesis and that insulin activates 
a pre-existing molecule. 
As it has been reported that somatomedin C 
(IGFl), a factor with a structure analogous to in- 
sulin, acts on glial cells [27], its effect on S6 kinase 
activity in astrocytes was examined. It was found 
that IGFl promoted stimulation of S6 kinase ac- 
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Fig.2. Time course of the stimulation of S6 kinase 
activity by insulin. Astrocytes were treated with insulin 
(10m6 M) for different time periods. Cytosolic extracts 
were prepared and S6 kinase assayed in the presence (0) 
or absence (0) of the heat-stable inhibitor for CAMP- 
dependent protein kinase. The basal value of S6 kinase 
activity corresponds to lo3 cpm 32P incorporated. 
Protein kinase C activity is shown at 0 and 60 min after 
insulin addition (+). 
tivity similar to that observed with insulin (fig.4, 
inset). 
TPA is known to induce phosphorylation of 
protein S6 in some cultured cells [8,9] and has been 
reported to activate S6 kinase in 3T3 cells [15]. We 
therefore examined the effect of this phorbol ester 
on S6 kinase activity in the cytosol of astrocytes. 
TPA stimulated S6 kinase activity more strongly 
than insulin (fig.4, inset). Fig.5 shows the time 
course of TPA-stimulated S6 kinase, which is very 
similar to that observed with insulin. As protein 
kinase C is known to be the phorbol ester receptor 
we examined the activity of this kinase in the same 
experiment. In contrast to the S6 kinase increase, 
protein kinase C activity decreased rapidly in the 
cytosol after TPA addition. 70% of the protein 
kinase activity was lost after 15 min. This decrease 
may be due to a translocation towards the mem- 
brane, as has been previously observed in other 
cellular systems [28,29]. It therefore appears that 
protein kinase C, one enzyme phosphorylating S6 
in vitro, cannot be the S6 kinase activated in situ 
by TPA. Similarly, CAMP-dependent protein 
kinase and phosvitin kinase are excluded as their 
activities remained unmodified (table 1). 
I To date, S6 kinase stimulation by growth factors 
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Fig.3. Protein kinase C on endogenous substrates in 
cytosolic extracts from control and stimulated cells. 
Astrocytes were treated for 1 h with insulin (10m6 M) or 
TPA (lo-’ M). 15 gg cytosolic extracts were incubated 
with [y-32P]ATP in buffer A in the presence (+) or 
absence (-) of PL (phosphatidylserine, 10 @g/ml + 
diolein, 0.5 pg/ml) and Ca2’ (0.5 mM above EGTA). 
After 5 min incubation at 30°C the reaction products 
were analyzed by polyacrylamide gel electrophoresis and 
autoradiography. (A,C) Control cells, (B) insulin- 
treated cells, (D) TPA-treated cells. 
-log [insulin] M 
Fig.4. Dependence on insulin concentration of S6 kinase 
stimulation. Control (0) and cycloheximide-treated (0) 
astrocytes were treated with increasing concentrations of 
insulin. Cytosolic extracts were prepared and S6 kinase 
assayed. The inset compares S6 kinase activity promoted 
by insulin, IGFl and TPA. Each agent was added to cell 
cultures at lo-’ M for 1 h. 
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Fig.5. Time course of S6 kinase and protein kinase C 
activities after TPA addition. Astrocytes were treated 
with TPA (lo-’ M) for various times. Cytosolic extracts 
were prepared and kinases assayed. 
activating tyrosine kinases or by cell transforma- 
tion with oncogenes coding for such an enzyme has 
been observed in 3T3 fibroblasts [14,30], 3T3 
fibroblasts differentiated into adipocytes [ 151, 
oocytes [16] and astrocytes (this work). These 
results suggest hat S6 kinase stimulation is linked 
to tyrosine kinase activation. However, the rela- 
tionship between tyrosine kinase and S6 kinase re- 
mains to be elucidated. Several hypotheses may be 
considered. Among them activation of S6 kinase 
by phosphorylation is supported by the observa- 
tion that phosphatase inhibitors must be present in 
homogenates to keep the S6 kinase in an activated 
form [31]. But there is as yet no direct demonstra- 
tion that tyrosine kinases phosphorylate S6 kinase. 
S6 kinase is also stimulated by TPA in 3T3 
fibroblasts [15] and astrocytes (this work), in- 
dicating the existence of another activation route, 
probably via the kinase C. Phosphorylation of S6 
kinase by kinase C could be possible but has not 
yet been demonstrated. An attractive explanation, 
at the present time, would be that TPA treatment 
of cells generates a proteolyzed form of kinase C 
which phosphorylates S6. This schema has a cer- 
tain amount of experimental support: (i) limited 
proteolysis of kinase C gives rise to kinase M [32], 
which has been shown to be very active on S6 in the 
absence of phospholipids and calcium [12]; (ii) 
treatment of cells with TPA results in increased 
165 
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kinase M activity [33,34]; (iii) an S6 kinase named 
PAKII activated by mild trypsin treatment has 
been purified by Traugh et al. [35,36]. PAKII 
shows several similarities to kinase M, but pro- 
teolysis of kinase C has been shown to generate 
different active derivatives under different condi- 
tions [31]. Thus the question must remain open as 
to the relationship between kinase M and PAKII. 
To test the validity of the different hypotheses 
(phosphorylation by tyrosine kinase and/or kinase 
C, limited proteolysis, etc.) the purification of 
insulin- and TPA-stimulated S6 kinase(s) is cur- 
rently in progress in our laboratory. 
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